tag:blogger.com,1999:blog-17095174973779325332023-11-15T05:58:16.901-08:007th European Biosimilars Congress<b>Theme: The developmental strategies and uptake of biosimilars through a decade in Europe</b>
<br><b>May 15-17, 2017</b>
<b><br>Munich, Germany</b>Badoni Victorhttp://www.blogger.com/profile/06792424120195888826noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-1709517497377932533.post-26308820339274269712016-11-19T03:04:00.002-08:002016-11-19T03:09:43.400-08:00Euro Biosimilars 2017<div dir="ltr" style="text-align: left;" trbidi="on">
<div id="section1" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; color: inherit; font-family: inherit; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 15px 0px; padding-bottom: 6px;">
About Conference</h3>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
The Organizing Committee is delighted to invite you to attend the 7<span style="box-sizing: border-box; font-weight: 700;">th</span><span style="box-sizing: border-box; font-weight: 700;"> European Biosimilars Congress</span> one of its remarkable Pharmaceutical conferences, to be held during May 15-17, 2017 in <span style="box-sizing: border-box; font-weight: 700;">Munich, Germany. </span><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/" target="_blank">European Biosimilars Congress</a> 2017 brings together scientists, researchers and CROs from around the world. With the approval of second biosimilar by the USFDA-Inflectra the biosimilars market is owned to experience a exponential growth over the coming few years. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
At <a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;">Euro Biosimilars 2017</a> meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Why to attend???</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Conduct demonstrations, distribute information, meet with current and potential Scientists to update yourself with latest technological advancememts and new research, and receive name recognition at this 3-days' event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in the era of follow-on-biologics and biosimilars are hallmarks of this conference.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Target Audience:</div>
<ul style="box-sizing: border-box; margin-bottom: 10px; margin-top: 0px;">
<li style="box-sizing: border-box; text-align: justify;">Directors, CEO’s of Organizations</li>
<li style="box-sizing: border-box; text-align: justify;">Business Development Managers</li>
<li style="box-sizing: border-box; text-align: justify;">Chief Scientific Officers</li>
<li style="box-sizing: border-box; text-align: justify;">R&D Researchers from Biosimilar and Bioslogics Industries</li>
<li style="box-sizing: border-box; text-align: justify;">Professors, Associate Professors, Assistant Professors</li>
<li style="box-sizing: border-box; text-align: justify;">PhD Scholars</li>
<li style="box-sizing: border-box; text-align: justify;">Patent Attorneys</li>
<li style="box-sizing: border-box; text-align: justify;">Intellectual Property Attorneys</li>
<li style="box-sizing: border-box; text-align: justify;">Investment Analysts</li>
<li style="box-sizing: border-box; text-align: justify;">Association, Association presidents and professionals</li>
<li style="box-sizing: border-box; text-align: justify;">Noble laureates in Health Care and Medicine</li>
<li style="box-sizing: border-box; text-align: justify;">Bio instruments Professionals</li>
<li style="box-sizing: border-box; text-align: justify;">Bio-informatics Professionals</li>
<li style="box-sizing: border-box; text-align: justify;">Software development companies</li>
<li style="box-sizing: border-box; text-align: justify;">Research Institutes and members</li>
<li style="box-sizing: border-box; text-align: justify;">Supply Chain companies</li>
<li style="box-sizing: border-box; text-align: justify;">Manufacturing Companies</li>
<li style="box-sizing: border-box; text-align: justify;">CRO and DATA management Companies</li>
<li style="box-sizing: border-box; text-align: justify;">Training Institutes</li>
<li style="box-sizing: border-box; text-align: justify;">Business Entrepreneurs</li>
</ul>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Past Attendees Share Based on Professional Sectors:</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<div style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;">
<img alt="" src="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/upload-images/xbiosimilars-euro2017-14575.png.pagespeed.ic.Uaa61DL3KQ.webp" data-pagespeed-url-hash="451247720" height="95" style="border: 0px; box-sizing: border-box; height: 347px; vertical-align: middle; width: 730px;" width="200" /></div>
</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<br /></div>
<div style="box-sizing: border-box; margin-bottom: 10px;">
<br /></div>
<br style="box-sizing: border-box;" />
<br style="box-sizing: border-box;" />
<hr style="background: -webkit-linear-gradient(left, transparent, rgba(0, 0, 0, 0.498039), transparent); border: 0px; box-sizing: content-box; height: 1px; margin: 15px 0px; position: relative;" />
</div>
<div id="section2" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; color: inherit; font-family: inherit; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 15px 0px; padding-bottom: 6px;">
<br /></h3>
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; color: inherit; font-family: inherit; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 15px 0px; padding-bottom: 6px;">
Market Analysis</h3>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
As per market researchers, the global biosimilar market is expected to be worth $24 billion in 2019-at compound annual growth rate (CAGR) of some 65% from 2014.Clinical trials at global level would incur an approximate cost of few hundred crores.The estimated cost of developing biosimilars for global markets is $75-250 million, while developing traditional non-biologic generics costs about $2-3 million. With the introduction of Inflectra on April 06, 2016 the Biosimilar Market will grow at even higher rate.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Critical Analysis</span>:</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
The capital-intensive nature of the biosimilar business and long gestation periods between initial investment</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
and commercialization require biosimilar players to take a higher level of risk than their counterparts in the smallmolecule generics business, and this can be a significant barrier to entry for many start-ups.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Growth Potential of Biologics and Biosimilars Market in Germany</span></div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<img alt="" src="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/upload-images/xbiosimilars-euro2017-70356.png.pagespeed.ic.1RMEidKBPq.webp" data-pagespeed-url-hash="2228619195" style="border: 0px; box-sizing: border-box; height: 289px; vertical-align: middle; width: 579px;" /></div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Potential factors to affect biosimilars market penetration:</span></div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<img alt="" src="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/upload-images/xbiosimilars-euro2017-93011.png.pagespeed.ic.pWVNIqs4ck.webp" data-pagespeed-url-hash="3107734066" style="border: 0px; box-sizing: border-box; height: 334px; vertical-align: middle; width: 594px;" /></div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Importance & Scope:</span></div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
The European-based pharmaceutical industry makes a major contribution to the Europe, not just in financial terms but also in terms of high-trait employment. Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Major Biosimilars Associations in Europe</span></div>
<ul style="box-sizing: border-box; margin-bottom: 10px; margin-top: 0px;">
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/biosimilar-market-and-cost-analysis" style="box-sizing: border-box; color: #23527c; outline: 0px; text-decoration: none;">Pro Generika</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/emerging-biosimilars-in-therapeutics" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">German Association of Generic Manufacturers</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/biosimilar-market-and-cost-analysis" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">German Association of Research-Based Pharmaceutical Companies</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/entrepreneurs-investment-meet" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">German Association for the Pharmaceutical Industry</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/regulatory-approach-and-legal-issues-of-biosimilars" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">Generics and Biosimilars Initiative</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/biosimilar-market-and-cost-analysis" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">The Biosimilars Resource Center</a></li>
<li style="box-sizing: border-box; text-align: justify;"><a font-size:="" helvetica="" href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/current-challenges-of-biologics" style="box-sizing: border-box; color: #337ab7; text-decoration: none;">The Alliance for Safe Biologic Medicines</a></li>
</ul>
<br style="box-sizing: border-box;" />
<br style="box-sizing: border-box;" />
<hr style="background: -webkit-linear-gradient(left, transparent, rgba(0, 0, 0, 0.498039), transparent); border: 0px; box-sizing: content-box; height: 1px; margin: 15px 0px; position: relative;" />
</div>
<div id="sectionB" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; color: inherit; font-family: inherit; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 15px 0px; padding-bottom: 6px;">
Past Conference Report</h3>
<span style="box-sizing: border-box; font-weight: 700;">Euro Biosimilars 2016</span><br />
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Conference Series LLC hosted the <span style="box-sizing: border-box; font-weight: 700;">5<span style="box-sizing: border-box; font-size: 10.5px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> European Biosimilars Congress</span> at Hotel Meliá Valencia in Valencia, Spain during June 27-29, 2016.The conference was designed around the theme of “<span style="box-sizing: border-box; font-weight: 700;">The</span><span style="box-sizing: border-box; font-weight: 700;"> European perspective of Biologics and Biosimilars</span>” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering. Moreover, the networking sessions laid the foundation for some time worthy collaborations between many start-up and big industries. The post conference networking lunch session witnessed a number of B2B meetings that are turning up to be mutually beneficial to both the organizations who had gone in for the business meetings.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Euro Biosimilars 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars. This congress not only brought forward the latest developments in the field but also provided solutions to the numerous challenges encountered in developing a biosimilar.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
Conference Series LLC would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Delegates, Media Partners and Exhibitors for their participation in Euro Biosimilars 2016.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Laszlo Endrenyi, </span>University of Toronto, Canada</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Candida Fratazzi</span>, BBCR Consulting, USA</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Kamali Chance, </span>Quintiles Inc., USA</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Andreu Soldevila</span>, Lean Biopro, Spain</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Ruideger Janwkosky</span>, Cinfa Biotech GmbH, Germany<br />
</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
<br style="box-sizing: border-box;" />
We on behalf of the conference specially thank the exhibitors for their participation in the congress and also the media partners for their wonderful marketing of the event. Conference Series LLC also took the privilege of felicitating Euro Biosimilars 2016 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.</div>
<div style="box-sizing: border-box; margin-bottom: 10px; text-align: justify;">
With the enormous feedback from the participants and supporters of Euro Biosimilars 2016, we are glad to announce 7<span style="box-sizing: border-box; font-size: 10.5px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> European Biosimilars Congress during May 15-17, 2017 at Munich, Germany and also invite you to participate at our 6<span style="box-sizing: border-box; font-size: 10.5px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> International Conference and Exhibition on Biologics and Biosimilars through October 19-21, 2016 at Houston, TX, USA.</div>
<div style="box-sizing: border-box; margin-bottom: 10px;">
<br /></div>
<br style="box-sizing: border-box;" />
<a href="http://www.conferenceseries.com/Past_Reports/euro-biosimilars-2016-past" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank"><span class="btn btn-warning btn-xs" style="background-color: #f0ad4e; background-image: linear-gradient(rgb(240 , 173 , 78) 0px , rgb(235 , 147 , 22) 100%); background-repeat: repeat-x; border-radius: 3px; border: 1px solid rgb(227 , 141 , 19); box-shadow: rgba(255 , 255 , 255 , 0.14902) 0px 1px 0px inset , rgba(0 , 0 , 0 , 0.0745098) 0px 1px 1px; box-sizing: border-box; color: white; cursor: pointer; display: inline-block; font-size: 12px; line-height: 1.5; margin-bottom: 0px; padding: 1px 5px; text-align: center; text-shadow: rgba(0 , 0 , 0 , 0.2) 0px -1px 0px; vertical-align: middle; white-space: nowrap;">Past Reports</span></a> <a href="http://www.conferenceseries.com/Past_Reports/euro-biosimilars-2016-gallery" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank"><span class="btn btn-warning btn-xs" style="background-color: #f0ad4e; background-image: linear-gradient(rgb(240 , 173 , 78) 0px , rgb(235 , 147 , 22) 100%); background-repeat: repeat-x; border-radius: 3px; border: 1px solid rgb(227 , 141 , 19); box-shadow: rgba(255 , 255 , 255 , 0.14902) 0px 1px 0px inset , rgba(0 , 0 , 0 , 0.0745098) 0px 1px 1px; box-sizing: border-box; color: white; cursor: pointer; display: inline-block; font-size: 12px; line-height: 1.5; margin-bottom: 0px; padding: 1px 5px; text-align: center; text-shadow: rgba(0 , 0 , 0 , 0.2) 0px -1px 0px; vertical-align: middle; white-space: nowrap;">Gallery</span></a> <br />
<br style="box-sizing: border-box;" />
<hr style="background: -webkit-linear-gradient(left, transparent, rgba(0, 0, 0, 0.498039), transparent); border: 0px; box-sizing: content-box; height: 1px; margin: 15px 0px; position: relative;" />
<br style="box-sizing: border-box;" />
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; color: inherit; font-family: inherit; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 15px 0px; padding-bottom: 6px;">
Past Conference Report</h3>
<span style="box-sizing: border-box; font-weight: 700;">Biosimilars 2015</span><br />
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
We hosted the <span style="box-sizing: border-box; font-weight: 700;">4<span style="box-sizing: border-box; font-size: 9.75px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> International Conference and Exhibition on Biologics and Biosimilars</span> at Double Tree by Hilton Hotel Baltimore, USA during October 26-28, 2015.The conference was designed around the theme of “<span style="box-sizing: border-box; font-weight: 700;"> The future of Next Generation Biologics and Biosimilars</span>” and was a great success where eminent keynote speakers from various reputed companies made their resplendent presence and addressed the gathering.</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
Biosimilars 2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Biologics and Biosimilars.</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
OMICS International would like to convey a warm gratitude to all the Honorable guests, Keynote Speakers, Media Partners, Exhibitors and Covance Laboratories as sponsors of Biosimilars 2015:</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Patrick Lucy, </span>Pfenex Inc., USA<br />
<span style="box-sizing: border-box; font-weight: 700;">Kamali Chance, </span>Quintiles Inc., USA<br />
<span style="box-sizing: border-box; font-weight: 700;">Christopher Leintz</span>, Pfizer, USA</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Mark A Emalfarb, </span> Dyadic Internatrional, USA</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Sarfaraz K NIazi, </span>Therapeutic Proteins International, USA</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
<span style="box-sizing: border-box; font-weight: 700;">Angela Furlanetto, </span>Dimock Stratton LLP, Canada</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
<br style="box-sizing: border-box;" />
On behalf of the conference, we congratulate the <span style="box-sizing: border-box; font-weight: 700;">Best Poster awardees</span> for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavours.<br />
<br style="box-sizing: border-box;" />
We had taken the privilege of felicitating Biosimilars 2015 Organizing Committee, Keynote Speakers, Chair and Co-Chairs whose support made conference a great success.</div>
<div style="box-sizing: border-box; color: #393a3b; font-family: Arial; font-size: 13px; margin-bottom: 10px; text-align: justify;">
With the enormous feedback from the participants and supporters of Biosimilars 2015, OMICS International is glad to announce 5<span style="box-sizing: border-box; font-size: 9.75px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> European Biosimilars Congress during June 27-29, 2016 at Valencia, Spain and 6<span style="box-sizing: border-box; font-size: 9.75px; line-height: 0; position: relative; top: -0.5em; vertical-align: baseline;">th</span> International Conference and Exhibition on Biologics and Biosimilars through October 20-22, 2016 at Houston, USA</div>
<br style="box-sizing: border-box;" />
<a href="http://www.conferenceseries.com/Past_Reports/biosimilars-2015-past" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank"><span class="btn btn-warning btn-xs" style="background-color: #f0ad4e; background-image: linear-gradient(rgb(240 , 173 , 78) 0px , rgb(235 , 147 , 22) 100%); background-repeat: repeat-x; border-radius: 3px; border: 1px solid rgb(227 , 141 , 19); box-shadow: rgba(255 , 255 , 255 , 0.14902) 0px 1px 0px inset , rgba(0 , 0 , 0 , 0.0745098) 0px 1px 1px; box-sizing: border-box; color: white; cursor: pointer; display: inline-block; font-size: 12px; line-height: 1.5; margin-bottom: 0px; padding: 1px 5px; text-align: center; text-shadow: rgba(0 , 0 , 0 , 0.2) 0px -1px 0px; vertical-align: middle; white-space: nowrap;">Past Reports</span></a> <a href="http://www.conferenceseries.com/Past_Reports/biosimilars-2015-gallery" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank"><span class="btn btn-warning btn-xs" style="background-color: #f0ad4e; background-image: linear-gradient(rgb(240 , 173 , 78) 0px , rgb(235 , 147 , 22) 100%); background-repeat: repeat-x; border-radius: 3px; border: 1px solid rgb(227 , 141 , 19); box-shadow: rgba(255 , 255 , 255 , 0.14902) 0px 1px 0px inset , rgba(0 , 0 , 0 , 0.0745098) 0px 1px 1px; box-sizing: border-box; color: white; cursor: pointer; display: inline-block; font-size: 12px; line-height: 1.5; margin-bottom: 0px; padding: 1px 5px; text-align: center; text-shadow: rgba(0 , 0 , 0 , 0.2) 0px -1px 0px; vertical-align: middle; white-space: nowrap;">Gallery</span></a> </div>
<div id="sectionB" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<br /></div>
<div id="sectionB" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<h2 class="heading-highlights" style="background: rgb(56, 138, 187); border-radius: 4px 4px 0px 0px; box-shadow: rgba(0, 0, 0, 0.2) 1px 1px 1px; box-sizing: border-box; color: white; font-size: 22px; font-weight: 500; line-height: 1.1; margin: 0px; padding: 5px 45px; position: relative;">
Conference Highlights</h2>
<div class="conference-highlights-body" style="border-bottom-color: rgb(227, 227, 227); border-bottom-style: solid; border-image: initial; border-left-color: rgb(227, 227, 227); border-left-style: solid; border-right-color: rgb(227, 227, 227); border-right-style: solid; border-top-color: initial; border-top-style: initial; border-width: 0px 1px 1px; box-shadow: rgba(0, 0, 0, 0.2) 0px 0px 4px; box-sizing: border-box; max-height: 660px; overflow: auto; padding: 20px 10px 0px;">
<ul class="list-group show" style="border-radius: 4px; box-shadow: rgba(0, 0, 0, 0.0745098) 0px 1px 2px; box-sizing: border-box; margin-bottom: 0px; margin-top: 0px; padding-left: 0px;">
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top-left-radius: 4px; border-top-right-radius: 4px; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/current-challenges-of-biologics" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Current Challenges of Biologics">Current Challenges of Biologics</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/emerging-biosimilars-in-therapeutics" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Emerging Biosimilars in Therapeutics">Emerging Biosimilars in Therapeutics</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/analytical-strategies-for-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Analytical Strategies for Biosimilars">Analytical Strategies for Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/regulatory-approach-and-legal-issues-of-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Regulatory Approach and Legal Issues of Biosimilars">Regulatory Approach and Legal Issues of Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/innovative-approach-for-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Innovative Approach for Biosimilars">Innovative Approach for Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/consequences-of-brexit-on-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Consequences of Brexit on Biosimilars">Consequences of Brexit on Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/globalization-of-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Globalization of Biosimilars">Globalization of Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/clinical-development-of-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Clinical Development of Biosimilars">Clinical Development of Biosimilars</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/biosimilar-market-and-cost-analysis" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Biosimilar Market and Cost Analysis">Biosimilar Market and Cost Analysis</a></li>
<li class="list-group-item" style="border-bottom: 1px solid rgb(221, 221, 221); border-image: initial; border-left: none; border-right: none; border-top: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/pharmacovigilance-on-biosimilars" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Pharmacovigilance on Biosimilars">Pharmacovigilance on Biosimilars</a></li>
<li class="list-group-item" style="border-bottom-left-radius: 4px; border-bottom-right-radius: 4px; border: none; box-sizing: border-box; display: block; margin-bottom: 0px; padding: 4px; position: relative;"><a href="http://biosimilars-biologics.pharmaceuticalconferences.com/europe/events-list/entrepreneurs-investment-meet" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" title="Entrepreneurs Investment Meet">Entrepreneurs Investment Meet</a></li>
</ul>
</div>
</div>
<div id="sectionB" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<br /></div>
<div id="sectionB" style="background-color: white; box-sizing: border-box; color: #333333; font-family: "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 14px;">
<h3 style="border-bottom: 1px dashed rgb(227, 227, 227); box-sizing: border-box; font-size: 18px; font-weight: 500; line-height: 1.1; margin: 0px 0px 5px; padding-bottom: 6px;">
Special Issues</h3>
<div style="box-sizing: border-box; margin-bottom: 10px;">
All accepted abstracts will be published in respective Journals.</div>
<ul style="box-sizing: border-box; margin-bottom: 10px; margin-top: 0px;">
<li style="box-sizing: border-box;"><a href="http://www.omicsonline.org/editorialboard-bioanalysis-biomedicine-open-access.php" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank" title="Journal of Bioanalysis & Biomedicine">Journal of Bioanalysis & Biomedicine</a></li>
<li style="box-sizing: border-box;"><a href="http://www.omicsonline.org/editorialboard-bioequivalence-bioavailability-open-access.php" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank" title="Journal of Bioequivalence & Bioavailability">Journal of Bioequivalence & Bioavailability</a></li>
<li style="box-sizing: border-box;"><a href="http://www.scitechnol.com/editorialboard-pharmaceutical-sciences-emerging-drugs" style="background-color: transparent; box-sizing: border-box; color: #337ab7; text-decoration: none;" target="_blank" title="Journal of Pharmaceutical Sciences & Emerging Drugs">Journal of Pharmaceutical Sciences & Emerging Drugs</a></li>
</ul>
<div class="digital-identifier" style="background-attachment: initial; background-clip: initial; background-image: url("../images/sprite_flags_social.png"); background-origin: initial; background-position: 0px -1035px; background-repeat: no-repeat; background-size: initial; box-sizing: border-box; margin-bottom: 10px; padding-bottom: 80px;">
Abstracts will be provided with Digital Object Identifier by CrossRef</div>
</div>
</div>
Badoni Victorhttp://www.blogger.com/profile/06792424120195888826noreply@blogger.com1